Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare work of breathing on different levels of high flow respiratory support on infants born between 27 and 37 weeks gestation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03529994
Study type Observational
Source Christiana Care Health Services
Contact
Status Completed
Phase
Start date April 15, 2018
Completion date August 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT03091504 - Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula N/A
Not yet recruiting NCT04560842 - The Efficacy of High-flow Nasal Cannula Oxygen Therapy in Sepsis Patients N/A
Completed NCT02793674 - HFNC Flow Titration and Effort of Breathing in the PICU N/A
Completed NCT02943863 - Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia N/A
Recruiting NCT05505279 - Ventilatory Effects of THRIVE During EBUS Phase 3
Completed NCT03066934 - A Multicentered Study on Efficiency of Noninvasive Ventilation Procedures
Completed NCT03148262 - High-Flow Nasal Cannula and Desaturation Episodes in the Morbidly Obese Patients N/A
Not yet recruiting NCT04293991 - High Flow Nasal Cannula in Immunocompromised Patient With Acute Respiratory Failure N/A
Recruiting NCT06306651 - High Flow Nasal Cannula and Conventional Oxygen Therapy in the Postoperative Management of Patients With Mild to Moderate Obstructive Sleep Apnea N/A
Recruiting NCT02958488 - Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks) N/A
Completed NCT03845244 - Weaning Protocol for High Flow Nasal Cannula Oxygen Therapy N/A
Completed NCT04965844 - Closed-loop Oxygen Control for High Flow Nasal Therapy N/A
Not yet recruiting NCT05467332 - Tracheal Positive Pressure During High Flow Nasal Oxygen Administration in Critically Ill Patients: a Physiologic Study.
Completed NCT04325906 - Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS N/A